2020年欧洲心脏病学会(ESC 2020)年会即将于8月29日-9月1日隆重开幕。受疫情影响,今年的会议改为线上召开,会议直播详细日程已在ESC官网公布。本次会议将公布4部ESC临床实践指南,12项Hot line研究,25项Late-Breaking Science研究等,会议共涉及400多个心血管主题,可谓一场值得期待的学术盛宴!注:下表标注时间均为北京时间。 慢性心力衰竭LBS1(8月29日 14:30 - 14:40) | NEDA 研究:436,360例患者的舒张功能和死亡率NEDA: Diastolic Function and Mortality in 436,360 individuals |
血脂LBS(8月29日 14:50 - 15:20) | Apolipoprotein C-III Reduction in Cardiovascular Disease | ANGPTL3 antisense oligonucleotide to lower triglycerides | Final Results of the EVAPORATE Trial |
冠心病LBS(8月29日 15:00 - 15:30) | Treatment for Patients with Stable Ischemic Heart Disease and Heart Failure | Trends in cardiovascular risk from 2004 to 2016 | Nationwide trends for myocardial infarction and mortality among type 2 diabetes patients |
房颤LBS 1(8月29日 16:15 - 16:45) | RATE-AF研究:永久性心房颤动心率控制治疗评价RATE-AF: RAte control Therapy Evaluation in permanent Atrial Fibrillation | CASA-AF 随机对照试验:LSPAF导管消融与胸腔镜手术消融的比较CASA-AF RCT - Catheter Ablation versus Thoracoscopic Surgical Ablation in LSPAF | STOP AF First:冷冻球囊导管消融术作为阵发性心房颤动的一线治疗方法STOP AF First: cryoballoon catheter ablation as a first line treatment for paroxysmal atrial fibrillation |
外周血管和脑血管疾病LBS(8月30日 15:00 - 15:10) | VOYAGER PAD and concomitant coronary artery disease |
慢性心力衰竭LBS 2(8月30日 15:40 - 15:50) | Change in ejection fraction and mortality in 117,275 cases |
急性冠脉综合征LBS 1(8月30日 16:28 - 16:48) | Il-6 inhibition in acute ST-elevation myocardial infarction | BAMI - autologous cell therapy for the treatment of acute myocardial infarction |
房颤LBS 2(8月30日 17:10 - 17:20) | ELDECARE-AF研究:艾多沙班15 mg用于不适用标准抗凝剂的日本老年房颤患者ELDECARE-AF: Edoxaban 15 mg for elderly Japanese AF patients ineligible for standard anticoagulants |
高血压LBS(8月31日 14:30 - 14:40) | 抗高血压药物与癌症风险:BPLTTC研究的IPD 荟萃分析Antihypertensive drugs and cancer risk: an IPD meta-analysis in the BPLTTC |
糖尿病与心脏LBS(8月31日 15:00 - 15:20) | VERTIS CV Heart Failure研究结果VERTIS CV Heart Failure Results | Effect of BMI and Polygenic Scores on Lifetime Risk of Diabetes |
女性心血管疾病LBS(8月31日 16:01 - 16:11) | Juvenile Myocardial Infarction in Women |
心血管药物治疗LBS(9月01日 14:30 - 14:40) | THEMIS-PAD研究:替格瑞洛在合并与不合并外周动脉疾病患者中的应用THEMIS-PAD Ticagrelor in Patients with and without Peripheral Artery Disease |
危险因素及预防LBS(9月01日 15:00 - 15:10) | Lifetime Risk of Cardiovascular Disease Based on Cumulative Exposure to Lipoproteins and SBP |
晕厥和心动过缓LBS(9月01日 15:30 - 15:40) | BioSync CLS研究:起搏器治疗倾斜诱导的血管迷走性晕厥BioSync CLS: pacing for tilt-induced asystolic vasovagal syncope |
急性冠脉综合征LBS 2(9月09日 15:40 - 16:10) | 替格瑞洛与氯吡格雷在老年急性冠脉综合征患者中的应用Ticagrelor and Clopidogrel in Elderly with Acute Coronary Syndrome | FAST-MI注册研究中的ESC-ACVC QIs ESC-ACVC QIs in FAST-MI Registries | Association Between Betablocker dose and Cardiovascular Outcomes After Myocardial Infarction |
|